Resmed (RMD) Revenue (2009 - 2026)

Resmed (RMD) has 18 years of Revenue data on file, last reported at $1.4 billion in Q1 2026.

• For the quarter ending Q1 2026, Revenue rose 10.81% year-over-year to $1.4 billion; the trailing twelve-month figure through Mar 2026 stood at $5.5 billion (up 10.28% YoY), and the FY2025 full-year result was $5.1 billion, up 9.84% from the prior year.
• Revenue for Q1 2026 stood at $1.4 billion, up from $1.4 billion in the prior quarter.
• Across five years, Revenue topped out at $1.4 billion in Q1 2026 and bottomed at $864.5 million in Q1 2022.
• The 5-year median for Revenue is $1.2 billion (2024), against an average of $1.2 billion.
• The widest annual swing landed in 2022, when Revenue gained 4.41%; it then rose 29.2% in 2023.
• A 5-year view of Revenue shows it stood at $1.0 billion in 2022, then grew by 12.48% to $1.2 billion in 2023, then increased by 10.26% to $1.3 billion in 2024, then increased by 10.98% to $1.4 billion in 2025, then gained by 0.6% to $1.4 billion in 2026.
• The last three Revenue figures came in at $1.4 billion (Q1 2026), $1.4 billion (Q4 2025), and $1.3 billion (Q3 2025), per Business Quant data.

Peer Comparison